The COVID-19 pandemic’s impact on rheumatic disease patients’ satisfaction with access to medical services-Reference-Cited by-同舟云学术

The COVID-19 pandemic’s impact on rheumatic disease patients’ satisfaction with access to medical services

Published:2023-09-30 Issue:1 Volume:44 Page:157-164
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Marinkov Aleksandar^ORCID,Dimova Rositsa^ORCID,Karalilova Rositsa^ORCID,Keskinova Donka^ORCID,Bahariev Dimitar^ORCID,Batalov Konstantin^ORCID,Popova Velichka^ORCID,Batalov Zguro^ORCID,Batalov Anastas^ORCID

Funder

Medical University of Plovdiv

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-023-05413-3.pdf

Reference22 articles.

1. Landewé RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, Combe B, Galli M, Gossec L, Iagnocco A, Isaacs JD, Mariette X, McInnes I, Mueller-Ladner U, Openshaw P, Smolen JS, Stamm TA, Wiek D, Schulze-Koops H (2020) EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis 79:851–858

2. Leipe J, Hoyer BF, Iking-Konert C, Schulze-Koops H, Specker C, Krüger K (2020) SARS-CoV-2 & Rheuma: Konsequenzen der SARS-CoV-2-Pandemie für Patienten mit entzündlich rheumatischen Erkrankungen. Ein Vergleich der Handlungsempfehlungen rheumatologischer Fachgesellschaften und Risikobewertung verschiedener antirheumatischer Therapien [SARS-CoV-2 & rheumatic disease: Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments]. Z Rheumatol 79:686–691

3. Shin YH, Shin JI, Moon SY, Jin HY, Kim SY, Yang JM, Cho SH, Kim S, Lee M, Park Y, Kim MS, Won HH, Hong SH, Kronbichler A, Koyanagi A, Jacob L, Smith L, Lee KH, Suh DI, Lee SW, Yon DK (2021) Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study. Lancet Rheumatol 3(10):e698–e706. https://doi.org/10.1016/S2665-9913(21)00151-X

4. Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC (2022) COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol 18:191–204. https://doi.org/10.1038/s41584-022-00755-x

5. Poggenborg RP, Madsen OR, Sweeney AT, Dreyer L, Bukh G, Hansen A (2022) Patient-controlled outpatient follow-up on demand for patients with rheumatoid arthritis: a 2-year randomized controlled trial. Clin Rheumatol 41:2617. https://doi.org/10.1007/s10067-021-05674-y